Position in MYGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$825,156
New position
Shares Held
183,368
first reported quarter
Ownership
0.194%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Vanguard Global Advisers, LLC holds $1,197,338,329 across 38 Diagnostics & Research names. MYGN ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
822,047 | $404,060,761 | |
| 2 | DHR |
Danaher Corp /De/
|
1,376,322 | $260,950,651 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
174,862 | $98,253,209 | |
| 4 | A |
Agilent Technologies, Inc.
|
618,952 | $70,548,148 | |
| 5 | WAT |
Waters Corp /De/
|
214,292 | $63,816,157 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
371,124 | $63,291,486 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
44,483 | $56,101,959 | |
| 8 | LH |
Labcorp Holdings Inc.
|
181,982 | $48,554,617 |
All Filings in MYGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $825,156 | 183,368 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||